Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-026144
Filing Date
2024-11-05
Accepted
2024-11-05 16:25:05
Documents
1
Period of Report
2024-11-01

Document Format Files

Seq Description Document Type Size
1 form4-11052024_041101.html 4  
1 form4-11052024_041101.xml 4 7730
  Complete submission text file 0001415889-24-026144.txt   9283
Mailing Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850
Business Address 9713 KEY WEST AVENUE, SUITE 400 ROCKVILLE MD 20850 301-517-5556
MAXCYTE, INC. (Issuer) CIK: 0001287098 (see all company filings)

EIN.: 522210438 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
(CF Office: 08 Industrial Applications and Services)

Mailing Address 20 FIRSTFIELD ROAD, #250 GAITHERSBURG MD 20878
Business Address
Erck Stanley C (Reporting) CIK: 0001342826 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40674 | Film No.: 241427855